Diagnosis of metastasis in castration-resistant prostate cancer patients: decision algorithm in imaging tests

• Published in: Actas urológicas españolas (English ed.) Vol. 43; no. 2; pp. 55 - 61
• Main Authors: Juárez-Soto, A, Garín-Ferreira, J M, Rodríguez-Fernández, A, Tirado-Hospital, J L, González-Serrano, M T, Moreno-Jiménez, J, Medina-López, R, Baena-González, V
• Format: Journal Article
• Language: English; Spanish
• Published: Spain 01.03.2019
• Subjects: Algorithms; Bone Neoplasms - diagnostic imaging; Bone Neoplasms - secondary; Clinical Decision-Making; Humans; Magnetic Resonance Imaging; Male; Positron Emission Tomography Computed Tomography; Practice Guidelines as Topic; Prostatic Neoplasms, Castration-Resistant - pathology; Sensitivity and Specificity; Cáncer de próstata; Cáncer de próstata resistente a la castración metastásico (CPRCm); Diagnostic imaging tests; Metastatic castration-resistant prostate cancer (mCRPC); Prostate cancer; Pruebas de diagnóstico por la imagen
• ISSN: 2173-5786
• DOI: 10.1016/j.acuro.2018.05.011

In castration-resistant prostate cancer (CRPC), early detection of metastases is essential for the selection of treatment, and prevention of bone complications. However detecting incipient metastases remains a challenge as the conventional radiological tests (bone scintigraphy or computerised tomography) lack sufficient sensitivity. Diagnostic imaging techniques are currently available that have greater sensitivity and specificity, but are little used due to shortfalls in the recommendations. To create an algorithm that indicates the most suitable diagnostic imaging techniques for the different M0 CRPC patient profiles based on the scientific evidence. Meetings were held with eight experts in Urology, Pathological Anatomy, Radiodiagnostics and Nuclear Medicine organised by the Andalusian Association of Urology, in which the recommendations and scientific evidence on each of the diagnostic imaging techniques were reviewed. We present the current recommendations for the detection of metastasis in M0 CRPC patients, the patients that would benefit from early detection, and summarise the evidence to support the use of each of the new techniques. Techniques such as F-Choline PET/CT or DWWB MRI and probably open MRI have been demonstrated to have good sensitivity and specificity for patients with low PSA (<10ng/ml). Their inclusion in routine clinical practice will help improve the early detection of metastasis in CRPC patients.